Radiotherapy Alone vs. Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein-Barr Virus DNA Post-Induction Chemotherapy

F.F. Kong,G.S. Pan,C. Du,C. Hu,H.M. Ying

International journal of radiation oncology, biology, physics（2023）

引用 0|浏览9

暂无评分

摘要

IC+RT displayed similar survival outcomes as IC+CCRT/AC for NPC patients with negative post-IC EBV DNA. Our current data seems not to support the routine use of concurrent or adjuvant chemotherapy after IC for unselected patients.

查看译文

关键词

nasopharyngeal carcinoma patients,radiotherapy,adjuvant chemoradiotherapy,epstein-barr,post-induction

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要